Sanai Health Industry Group Company Limited (HKG:1889)
Hong Kong · Delayed Price · Currency is HKD 0.1560
-0.0280 (-15.22%)
Jul 31, 2026, 3:57 PM HKT
HKG:1889 Ratios and Metrics
Market cap in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 24 | 76 | 59 | 205 | 256 | 383 | |
Market Cap Growth | -55.43% | 29.87% | -71.35% | -19.65% | -33.31% | 38.89% |
Enterprise Value | -240 | -215 | -229 | 94 | 256 | 242 |
Last Close Price | 0.16 | 0.50 | 0.39 | 1.60 | 2.00 | 3.13 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | - | 11.31 | 10.01 | 7.74 | 34.61 |
PS Ratio | 0.25 | 0.80 | 0.65 | 1.73 | 1.29 | 4.62 |
PB Ratio | 0.07 | 0.21 | 0.16 | 0.69 | 0.88 | 1.42 |
P/TBV Ratio | 0.07 | 0.23 | 0.17 | 0.71 | 0.94 | 1.62 |
P/FCF Ratio | - | - | 5.21 | 0.58 | - | - |
P/OCF Ratio | - | - | 4.69 | 0.58 | - | - |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | - | - | - | 0.79 | 1.29 | 2.92 |
EV/EBITDA Ratio | - | - | - | 3.95 | 3.61 | 7.01 |
EV/EBIT Ratio | - | - | - | 4.62 | 3.81 | 7.98 |
EV/FCF Ratio | - | - | - | 0.27 | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.14 | 0.14 | 0.12 | 0.23 | 0.28 | - |
Debt / EBITDA Ratio | - | - | - | 2.78 | 1.13 | - |
Debt / FCF Ratio | - | - | 3.95 | 0.20 | - | - |
Net Debt / Equity Ratio | -0.81 | -0.81 | -0.85 | -1.00 | 0.19 | -0.08 |
Net Debt / EBITDA Ratio | 12.79 | 12.79 | 23.82 | -12.54 | 0.78 | -0.60 |
Net Debt / FCF Ratio | 4.85 | 4.85 | -28.11 | -0.84 | -0.87 | 0.43 |
Asset Turnover | 0.19 | 0.19 | 0.20 | 0.28 | 0.51 | 0.23 |
Inventory Turnover | 9.86 | 9.86 | 13.21 | 169.94 | 41.26 | 3.07 |
Quick Ratio | 3.29 | 3.29 | 3.10 | 3.27 | 2.82 | 1.91 |
Current Ratio | 3.60 | 3.60 | 3.20 | 3.28 | 2.82 | 2.10 |
Return on Equity (ROE) | -7.86% | -7.86% | -4.48% | 4.16% | 14.80% | 8.02% |
Return on Assets (ROA) | -3.24% | -3.24% | -2.15% | 3.00% | 10.66% | 5.13% |
Return on Invested Capital (ROIC) | -45.63% | -40.51% | -56.13% | 6.84% | 14.75% | 8.39% |
Return on Capital Employed (ROCE) | -7.10% | -7.10% | -4.10% | 6.80% | 23.00% | 11.20% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | -102.83% | -32.08% | 8.84% | 9.99% | 12.92% | 2.89% |
FCF Yield | -252.96% | -78.92% | 19.21% | 171.91% | -24.86% | -12.43% |
Buyback Yield / Dilution | -5.23% | -5.20% | 4.19% | -5.08% | -17.66% | - |